News Column

TETRALOGIC PHARMACEUTICALS CORP FILES (8-K) Disclosing Submission of Matters to a Vote of Security Holders

May 19, 2014

Item 5.07 Submission of Matters to a Vote of Security Holders.



On May 16, 2014, TetraLogic Pharmaceuticals Corporation (the "Company") held its Annual Meeting of Stockholders. The following proposals were submitted by the Company's Board of Directors to a vote of the Company's stockholders and the final results of the voting on each proposal are noted below.

Proposal 1 - Election of Directors

The stockholders elected the following individual to serve as a Class I director for a three-year term until the 2017 annual meeting of stockholders and until his successor is elected and qualified:

Name Votes For Votes Withheld Broker Non-Votes Douglas Reed, M.D. 11,500,162 1,167,693 3,373,855



Proposal 2 - Ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2014.

The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2014 as follows:

For Against Abstain Broker Non-Votes 15,535,118 503,899 2,893 - 2



--------------------------------------------------------------------------------


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters